| |
|
|
|
Adial Pharmaceuticals Inc  
|
|
2.33 0.38 (0.19%) |
11-30 16:00 |
|
Open: |
1.97 |
Pre close: |
1.95 |
Target:
|
2.76 
|
|
High: |
2.36 |
Low: |
1.97 |
Resistance:
|
2.36
2.76
|
|
Volume: |
2,487,308 |
Market Cap: |
34M |
Support:
|
1.92
1.65
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.97
|
MACD |
MACD(12,26):
|
0.06 |
|
MA(20): |
1.82 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
1.66 |
Stochastic Oscillator |
%K(14,3):
|
78.08 |
|
MA(250): |
1.64 |
%D(3): |
64.20 |
|
Average Volume(K) |
3-Month: |
268911
|
52-Week |
High:
|
4.00 |
|
10-Days: |
72371 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
70.82 |
Change(%): |
66.4 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-0.870 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-0.577 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
